Prosthetic Heart Valves: Multimedia

References

1. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. Feb 24 2009;119(7):1034-48. [Medline].

2. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis. Jan-Feb 2008;50(4):274-81. [Medline].

3. Akhtar RP, Abid AR, Zafar H, Khan JS. Aniticoagulation in patients following prosthetic heart valve replacement. Ann Thorac Cardiovasc Surg. Feb 2009;15(1):10-7. [Medline].

4. Daniels PR, McBane RD, Litin SC, Ward SA, Hodge DO, Dowling NF, et al. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Thromb Res. Feb 19 2009;[Medline].

5. Botta L, Bechan R, Yilmaz A, Di Bartolomeo R. Prosthetic valve endocarditis due to Brucella: successful outcome with a combined strategy. J Cardiovasc Med (Hagerstown). Mar 2009;10(3):257-8. [Medline].

6. Shapira Y, Vaturi M, Sagie A. Hemolysis associated with prosthetic heart valves: a review. Cardiol Rev. May-Jun 2009;17(3):121-4. [Medline].

7. Mehlman DJ. A pictorial and radiographic guide for identification of prosthetic heart valve devices. Prog Cardiovasc Dis. May-Jun 1988;30(6):441-64. [Medline].

8. Lengyel M. Diagnosis and treatment of left-sided prosthetic valve thrombosis. Expert Rev Cardiovasc Ther. Jan 2008;6(1):85-93. [Medline].

9. [Guideline] Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. Oct 9 2007;116(15):1736-54. [Medline].

10. [Guideline] Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis. The Task Force on Infective Endocarditis of the European Society of Cardiology. France: European Society of Cardiology. 2004;[Full Text].

11. Jeejeebhoy FM. Prosthetic heart valves and management during pregnancy. Can Fam Physician. Feb 2009;55(2):155-7. [Medline].

12. American College of Obstetricians and Gynecologists. ACOG Committee Opinion: safety of Lovenox in pregnancy. Obstet Gynecol. Oct 2002;100(4):845-6. [Medline].

13. Baddour LM, Wilson WR, Bayer AS. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. Circulation. Jun 14 2005;111(23):e394-434. [Medline].

14. Bussey HI. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves. J Heart Valve Dis. May 2004;13(3):319-24. [Medline].

15. Butany J, Ahluwalia MS, Munroe C, et al. Mechanical heart valve prostheses: identification and evaluation (erratum). Cardiovasc Pathol. Nov-Dec 2003;12(6):322-44. [Medline].

16. Butany J, Fayet C, Ahluwalia MS, et al. Biological replacement heart valves. Identification and evaluation. Cardiovasc Pathol. May-Jun 2003;12(3):119-39. [Medline].

17. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. Feb 1994;89(2):635-41. [Medline].

18. [Guideline] Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation. Jul 1 1997;96(1):358-66. [Medline].

19. Goldman ME. Echocardiographic doppler evaluation of prosthetic valve function and dysfunction. Adv Cardiol. 2004;41:179-84. [Medline].

20. Kahn S. Long-term outcomes with mechanical and tissue valves. J Heart Valve Dis. 2002;11, Suppl 1:S8-S14.

21. [Guideline] Lengyel M, Fuster V, Keltai M, et al. Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol. Nov 15 1997;30(6):1521-6. [Medline].

22. MacKenzie GS, Heinle SK. Echocardiography and Doppler assessment of prosthetic heart valves with transesophageal echocardiography. Crit Care Clin. Apr 1996;12(2):383-409. [Medline].

23. Piper C, Kprfer R, Horstkotte D. Prosthetic valve endocarditis. Heart. May 2001;85(5):590-3. [Medline].

24. Roudaut R, Lafitte S, Roudaut MF, et al. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases. J Am Coll Cardiol. Feb 19 2003;41(4):653-8. [Medline].

25. Stein PD, Alpert JS, Bussey HI, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest. Jan 2001;119(1 Suppl):220S-227S. [Medline].

26. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. Aug 8 1996;335(6):407-16. [Medline].

Further Reading

Keywords

heart valve replacement, leaky heart valve, heart valve surgery, prosthetic heart valve, artificial heart valves, implanted prosthetic device, primary valve failure, prosthetic valve endocarditis, prosthetic valve thrombosis, mechanical hemolytic anemia, acute prosthetic valve failure, bioprosthetic valves, prosthetic xenograft valves

Contributor Information and Disclosures

Author

Eric M Kardon, MD, FACEP, Attending Emergency Physician, Georgia Emergency Medicine Specialists; Physician, Division of Emergency Medicine, Athens Regional Medical Center
Eric M Kardon, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Medical Editor

Daniel J Dire, MD, FACEP, FAAP, FAAEM, Clinical Professor, Department of Emergency Medicine, University of Texas-Houston; Clinical Professor, Department of Pediatrics, University of Texas Health Sciences Center, San Antonio, Texas
Daniel J Dire, MD, FACEP, FAAP, FAAEM is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American Academy of Pediatrics, American College of Emergency Physicians, and Association of Military Surgeons of the US
Disclosure: Talecris Biotherapeutics Honoraria Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

A Antoine Kazzi, MD, Chair and Medical Director, Department of Emergency Medicine, American University of Beirut, Lebanon
A Antoine Kazzi, MD is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

David FM Brown, MD, Assistant Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.